GILEAD SCIENCES, INC. — Director's Dealing 2013

Aug 5, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2013-08-02

Reporting Person: Cogan John Francis (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-08-02	Common Stock	M	17000	$10.9925	Acquired	56542	Direct
2013-08-02	Common Stock	S	17000	$61.5081	Disposed	39542	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-08-02	Non-Qualified Stock Option (Right to Buy)	$10.9925	M	17000	Disposed	2015-07-27	Common Stock (17000)	Direct

Footnotes

F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.

F2: Options are 100% vested on the date of grant.

F3: Sale prices reported for the transactions reported here range from $61.40 to $61.81. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.